These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38053317)

  • 21. Pan-Cancer Analysis of
    Sokol ES; Pavlick D; Frampton GM; Ross JS; Miller VA; Ali SM; Lotan TL; Pardoll DM; Chung JH; Antonarakis ES
    Oncologist; 2019 Dec; 24(12):1526-1533. PubMed ID: 31292271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A decision support framework for genomically informed investigational cancer therapy.
    Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TiHoCL panel for canine lymphoma: a feasibility study integrating functional genomics and network biology approaches for comparative oncology targeted NGS panel design.
    Fibi-Smetana S; Inglis C; Schuster D; Eberle N; Granados-Soler JL; Liu W; Krohn S; Junghanss C; Nolte I; Taher L; Murua Escobar H
    Front Vet Sci; 2023; 10():1301536. PubMed ID: 38144469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIK3CA mutations matter for cancer in dogs.
    Kim JH
    Res Vet Sci; 2020 Dec; 133():39-41. PubMed ID: 32932196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants.
    Pestinger V; Smith M; Sillo T; Findlay JM; Laes JF; Martin G; Middleton G; Taniere P; Beggs AD
    Mol Diagn Ther; 2020 Jun; 24(3):339-349. PubMed ID: 32306292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds.
    Alsaihati BA; Ho KL; Watson J; Feng Y; Wang T; Dobbin KK; Zhao S
    Nat Commun; 2021 Aug; 12(1):4670. PubMed ID: 34344882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical implications of prospective genomic profiling of metastatic breast cancer patients.
    van Geelen CT; Savas P; Teo ZL; Luen SJ; Weng CF; Ko YA; Kuykhoven KS; Caramia F; Salgado R; Francis PA; Dawson SJ; Fox SB; Fellowes A; Loi S
    Breast Cancer Res; 2020 Aug; 22(1):91. PubMed ID: 32811538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-Generation Sequencing Concordance Analysis of Comprehensive Solid Tumor Profiling between a Centralized Specialty Laboratory and the Decentralized Personal Genome Diagnostics elio Tissue Complete Kitted Solution.
    Deak KL; Jackson JB; Valkenburg KC; Keefer LA; Robinson Gerding KM; Angiuoli SV; Datto MB; McCall SJ
    J Mol Diagn; 2021 Oct; 23(10):1324-1333. PubMed ID: 34314880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic and proteomic profiling for cancer diagnosis in dogs.
    Morris JS
    Vet J; 2016 Sep; 215():101-9. PubMed ID: 26848120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on genomics in veterinary oncology.
    Breen M
    Top Companion Anim Med; 2009 Aug; 24(3):113-21. PubMed ID: 19732729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [From panel diagnostics to comprehensive genomic analysis : Infobesity or empowerment?].
    Leichsenring J; Kazdal D; Ploeger C; Allgäuer M; Endris V; Volckmar AL; Neumann O; Kirchner M; Penzel R; Rempel E; Budczies J; Schirmacher P; Fröhling S; Stenzinger A
    Pathologe; 2019 May; 40(3):235-242. PubMed ID: 31089797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic profiling in oncology clinical practice.
    Rodríguez N; Viñal D; Rodríguez-Cobos J; De Castro J; Domínguez G
    Clin Transl Oncol; 2020 Sep; 22(9):1430-1439. PubMed ID: 31981077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical application of amplicon-based next-generation sequencing in cancer.
    Chang F; Li MM
    Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Canine Cancer Genomics: Lessons for Canine and Human Health.
    Ostrander EA; Dreger DL; Evans JM
    Annu Rev Anim Biosci; 2019 Feb; 7():449-472. PubMed ID: 30418802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards the Delivery of Precision Veterinary Cancer Medicine.
    Katogiritis A; Khanna C
    Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):809-818. PubMed ID: 31256903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
    Ramarao-Milne P; Kondrashova O; Patch AM; Nones K; Koufariotis LT; Newell F; Addala V; Lakis V; Holmes O; Leonard C; Wood S; Xu Q; Mukhopadhyay P; Naeini MM; Steinfort D; Williamson JP; Bint M; Pahoff C; Nguyen PT; Twaddell S; Arnold D; Grainge C; Basirzadeh F; Fielding D; Dalley AJ; Chittoory H; Simpson PT; Aoude LG; Bonazzi VF; Patel K; Barbour AP; Fennell DA; Robinson BW; Creaney J; Hollway G; Pearson JV; Waddell N
    ESMO Open; 2022 Aug; 7(4):100540. PubMed ID: 35849877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
    Kuo FC
    Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic Functional Annotation of Somatic Mutations in Cancer.
    Ng PK; Li J; Jeong KJ; Shao S; Chen H; Tsang YH; Sengupta S; Wang Z; Bhavana VH; Tran R; Soewito S; Minussi DC; Moreno D; Kong K; Dogruluk T; Lu H; Gao J; Tokheim C; Zhou DC; Johnson AM; Zeng J; Ip CKM; Ju Z; Wester M; Yu S; Li Y; Vellano CP; Schultz N; Karchin R; Ding L; Lu Y; Cheung LWT; Chen K; Shaw KR; Meric-Bernstam F; Scott KL; Yi S; Sahni N; Liang H; Mills GB
    Cancer Cell; 2018 Mar; 33(3):450-462.e10. PubMed ID: 29533785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood biomarkers for canine cancer, from human to veterinary oncology.
    Colombe P; Béguin J; Benchekroun G; Le Roux D
    Vet Comp Oncol; 2022 Dec; 20(4):767-777. PubMed ID: 35815441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.